Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications Jhalak DholakiaAlexander C. CohenPremal H. Thaker Immuno-oncology (RM Bukowski and JH Finke, Section Editors) 10 February 2022 Pages: 389 - 397
Cancer Immunotherapies: What the Perioperative Physician Needs to Know Robert S. AckermanAaron R. MunceyRosemarie E. Garcia Getting Anesthesiology and Critical Care (JP Cata, Section Editor) 10 February 2022 Pages: 399 - 414
Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission Ruth StuckeyJuan Francisco López RodríguezMaría Teresa Gómez-Casares Leukemia (A Aguayo, Section Editor) Open access 10 February 2022 Pages: 415 - 426
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management Shilpa PaulNicholas J. Short Leukemia (A Aguayo, Section Editor) 10 February 2022 Pages: 427 - 436
Emerging Role of Biomarkers in Testicular Germ Cell Tumors Maryam SoleimaniChristian KollmannsbergerLucia Nappi Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors) 10 February 2022 Pages: 437 - 442
The Symptom Experience in Pediatric Cancer: Current Conceptualizations and Future Directions Lindsay A. JibbSuzanne AmeringerSurabhi Sivaratnam Pediatric Oncology (KL Davis, Section Editor) 12 February 2022 Pages: 443 - 450
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms? Alejandro Garcia-AlvarezJorge Hernando CuberoJaume Capdevila Neuroendocrine Neoplasms (NS Reed, Section Editor) 16 February 2022 Pages: 451 - 461
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications Nicholas CamardaRichard TraversIris Z. Jaffe Cardio-oncology (JN Upshaw, Section Editor) 18 February 2022 Pages: 463 - 474
Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy Kalyan R. ChitturiEthan A. BurnsBarry H. Trachtenberg Cardio-oncology (JN Upshaw, Section Editor) 22 February 2022 Pages: 475 - 491
Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients Maria DiazJasmin Jo Neuro-oncology (KS Nevel, Section Editor) 18 February 2022 Pages: 493 - 500
Easing the Journey—an Updated Review of Palliative Care for the Patient with High-Grade Glioma Rita C. CroomsMargaret O. JohnsonAkanksha Sharma Neuro-oncology (KS Nevel, Section Editor) 22 February 2022 Pages: 501 - 515
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes Sara C. ParkeDavid Michael LangelierMichael Dean Stubblefield Cancer Rehabilitation (S Shahpar, Section Editor) 19 February 2022 Pages: 517 - 532
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions Thach-Giao TruongLucy Boyce KennedySapna P. Patel Melanoma (DB Johnson, Section Editor) 22 February 2022 Pages: 533 - 542